[Deposition and clearance of β-amyloid in the brain]

Koichi Wakabayashi1, Yasuo Miki

  • 1Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine.

Insights

Alzheimer's disease involves amyloid-beta protein (Aβ) deposition. Microglia and astrocytes clear Aβ, with astrocytes playing a key role in its perivascular clearance via a two-step process.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Context:

  • Alzheimer's disease (AD) is characterized by amyloid-beta protein (Aβ) deposition in the brain, forming senile plaques and vascular amyloid.
  • Aβ accumulation occurs in both AD patients and a substantial portion of non-demented elderly individuals, highlighting age-related changes.
  • Microglia and astrocytes are key glial cells involved in brain homeostasis and response to pathology.

Purpose:

  • To elucidate the roles of microglia and astrocytes in the clearance of amyloid-beta protein (Aβ).
  • To investigate the mechanisms underlying the perivascular clearance of Aβ, particularly the contribution of astrocytes.
  • To understand the cellular processes involved in Aβ degradation and removal from the brain parenchyma.

Summary:

  • Microglia are crucial for phagocytosing and proteolytically clearing both soluble and fibrillary forms of Aβ.
  • Astrocytes ensheath fibrillary Aβ with hypertrophic processes and internalize it into lysosomes, indicating a role in Aβ degradation.
  • Perivascular clearance of Aβ is a two-step mechanism involving uptake by glia limitans astrocytes and subsequent perivascular or transendothelial transport.

Impact:

  • This research deepens our understanding of glial cell functions in Aβ metabolism and brain clearance pathways.
  • Findings contribute to knowledge of Alzheimer's disease pathogenesis and potential therapeutic targets related to Aβ clearance.
  • Highlights the critical role of astrocytes in preventing Aβ accumulation and facilitating its removal from the brain.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K